Evidence map›Paper›PMID 31145145›Full record

ReviewCurrent opinion in psychiatry2019

Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions.

Chris Baeken, Anna-Katharine Brem, Martijn Arns, Andre R Brunoni, Igor Filipčić, Ana Ganho-Ávila, Berthold Langguth, Frank Padberg, Emmanuel Poulet, Fady Rachid and 3 more

Abstract readReview
In one paragraph

Review in Current opinion in psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Genetics and Neurobiology of Treatment-Resistant Depression-A Review.International journal of molecular sciences · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The Associative Thalamus: A Switchboard for Cortical Operations and a Promising Target for Schizophrenia.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chris BaekenDepartment of Psychiatry and Medical Psychology, Ghent University.
Anna-Katharine BremMax-Planck Institute of Psychiatry, Munich, Germany.
Martijn ArnsResearch Institute Brainclinics, Nijmegen, The Netherlands.
Andre R BrunoniDepartments of Internal Medicine and Psychiatry, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Igor FilipčićPsychiatric hospital 'Sveti Ivan'.
Ana Ganho-ÁvilaFaculty of Psychology and Educational Sciences, Center for Research in Neuropsychology and Cognitive Behavioral Intervention, University of Coimbra, Portugal.
Berthold LangguthDepartment of Psychiatry and Psychotherapy, University of Regensburg, Germany.
Frank PadbergDepartment of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
Emmanuel PouletINSERM, U1028, CNRS, UMR5292, Lyon Neuroscience Research Center, PSY-R2 Team, University Claude Bernard Lyon1, F-69000, France.
Fady RachidPrivate Practice, 7, place de la Fusterie, 1204 Geneva, Switzerland.
Alexander T SackDepartment of Cognitive Neuroscience, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Marie-Anne VanderhasseltDepartment of Experimental Clinical and Health Psychology.
Djamila BennabiDepartment of Clinical Psychiatry, CHU de Besançon, CIC-1431 INSERM, CHU de Besançon, EA481 Neurosciences, University Bourgogne Franche-Comte, FondaMental Foundation, 94000 Creteil, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewAfter three decades of clinical research on repetitive transcranial magnetic stimulation (rTMS), major depressive disorder (MDD) has proven to be the primary field of application. MDD poses a major challenge for health systems worldwide, emphasizing the need for improving clinical efficacy of existing rTMS applications and promoting the development of novel evidence-based rTMS treatment approaches. RECENT

findingsSeveral promising new avenues have been proposed: novel stimulation patterns, targets, and coils; combinatory treatments and maintenance; and personalization and stratification of rTMS parameters, and treatment of subpopulations. SUMMARY: This opinion review summarizes current knowledge in the field and addresses the future direction of rTMS treatment in MDD, facilitating the establishment of this clinical intervention method as a standard treatment option and continuing to improve response and remission rates, and take the necessary steps to personalize rTMS-based treatment approaches.

Indexed as

Transcranial Magnetic StimulationHumansMajor Depressive DisorderTreatment Outcome

Identifiers

PMID31145145
PMCPMC6688778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.